You are here: Home » News-CM » Companies » Results
Business Standard

Welcure Drugs & Pharmaceuticals reports standalone nil net profit/loss in the September 2018 quarter

Capital Market 

Reported sales nil

reported no net profit/loss in the quarter ended September 2018 as against net loss of Rs 0.01 crore during the previous quarter ended September 2017. There were no Sales reported in the quarter ended September 2018 and during the previous quarter ended September 2017.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, October 08 2018. 15:00 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU